Results 11 to 20 of about 7,143 (329)

Desensitizing efficacy of a universal dentin adhesive containing mesoporous bioactive glass on dentin hypersensitivity: a randomized clinical trial with a split-mouth model [PDF]

open access: yesScientific Reports
This split-mouth blinded randomized controlled study compared the efficacy of a desensitizing agent with oxalate/resin polymer and a universal adhesive containing mesoporous bioactive glass (MBG) for dentin hypersensitivity (DH) relief, using Schiff ...
Hyun-Jung Kim   +5 more
doaj   +2 more sources

The impact of three desensitizing materials on the shear strength between composite resin and dentin: an in-vitro study [PDF]

open access: yesBMC Oral Health
Background The study investigated the effect of three commercially available desensitizers on the shear bond strength (SBS) of two bulk fill composites and a conventional composite resin to dentin.
Hitesh Chohan   +9 more
doaj   +2 more sources

Effects of in-office bleaching agent combined with different desensitizing agents on enamel [PDF]

open access: yesJournal of Applied Oral Science, 2018
Objective: To analyze color change, microhardness and chemical composition of enamel bleached with in-office bleaching agent with different desensitizing application protocols.
Zeynep B. Kutuk   +3 more
doaj   +4 more sources

Influence of pain-relieving therapies on inflammation and the expression of proinflammatory neuropeptides after dental bleaching treatment [PDF]

open access: yesRestorative Dentistry & Endodontics, 2020
ObjectivesTo minimize the tooth sensitivity caused by in-office bleaching, many dentists use non-steroidal anti-inflammatory drugs and topical desensitizing gels containing potassium nitrate and sodium fluoride. This study aimed to evaluate the influence
Livia Maria Alves Valentim da Silva   +7 more
doaj   +1 more source

Occlusion, acid resistance, and elemental characterization of dentin treated with desensitizing agents. [PDF]

open access: diamondBraz Oral Res
Ribeiro MCLS   +6 more
europepmc   +2 more sources

Desensitization to biological agents used in rheumatology [PDF]

open access: yesRheumatology, 2020
Biological agents such as monoclonal antibodies and fusion proteins are widely used for the treatment of patients with various rheumatic disorders, influencing the quality of life, disability and even mortality in patients. However, biological agents can evoke adverse reactions of different grades of severity.
Joanna Makowska, Anna Lewandowska-Polak
openaire   +3 more sources

An in vitro evaluation of the effects of desensitizing agents on microleakage of Class V cavities [PDF]

open access: yes, 2016
Background: The aim of this study was to evaluate the effect of a desensitizing agent on microleakage of Class V cavities. Material and Methods: 72 premolar teeth were used. There were 6 groups.
Akgul, Sinem   +4 more
core   +4 more sources

Effect of a Desensitizing Agent on Shear Bond Strength of Ceramic Bracket on Previously Bleached Teeth

open access: yesApplied Sciences, 2023
This study aims to analyze the effect of desensitizing agents on the shear bond strength (SBS) of ceramic brackets after in-office bleaching procedures. Twenty-seven extracted premolars were equally divided into three groups (n = 9).
Muhammad Haikal Mahardhika   +3 more
doaj   +1 more source

Nano hydroxyapatite toothpaste as a treatment for dentine hypersensitivity: A systematic review

open access: yesSaudi Journal of Oral Sciences, 2021
Introduction: Dentin hypersensitivity (DH) is a common and painful clinical occurrence that can negatively impact patients' quality of life. An arsenal of different desensitizing molecules is available on the market, but no gold standard has yet to be ...
Hanan Oubenyahya
doaj   +1 more source

Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent [PDF]

open access: yesDrug Safety - Case Reports, 2015
Biological agents seem to have been more effective than classic immunosuppressive drugs; however, the adverse events including the hypersensitivity reactions are the main drawbacks of these drugs. We report a 35-year-old man who was treated with adalimumab for ankylosing spondylitis, had a local reaction on the injection site, and generalized itching ...
Demirel, Fevzi   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy